Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$382M |
| 2 |
Pfizer
PFE
|
+$266M |
| 3 |
Electronic Arts
EA
|
+$240M |
| 4 |
Eli Lilly
LLY
|
+$221M |
| 5 |
Colgate-Palmolive
CL
|
+$216M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Booking.com
BKNG
|
+$358M |
| 2 |
Comcast
CMCSA
|
+$263M |
| 3 |
Meta Platforms (Facebook)
META
|
+$258M |
| 4 |
AET
Aetna Inc
AET
|
+$257M |
| 5 |
Tesla
TSLA
|
+$189M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.14% |
| 2 | Technology | 13.55% |
| 3 | Financials | 11.85% |
| 4 | Consumer Staples | 10.18% |
| 5 | Industrials | 9.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2051
LifeVantage
LFVN
$80.1M
| $2.9M | ﹤0.01% |
670,271
+69,700
| +12% | +$307K |
|
|
KDNY
2052
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $2.89M | ﹤0.01% |
50,740
+14,360
| +39% | +$721K |
|
|
ONIT
2053
Onity Group
ONIT
$342M
| $2.89M | ﹤0.01% |
71,580
+53,675
| +300% | +$2.55M |
|
2054
Howmet Aerospace
HWM
$109B
| $2.88M | ﹤0.01% |
165,999
-1,339,599
| -89% | -$27.3M |
|
|
AAIC
2055
DELISTED
Arlington Asset Investment Corp.
AAIC
| $2.88M | ﹤0.01% |
+210,875
| New | +$3.03M |
|
2056
Friedman Industries
FRD
$244M
| $2.88M | ﹤0.01% |
507,000
+22,900
| +5% | +$133K |
|
|
AHGP
2057
DELISTED
Alliance Holdings GP
AHGP
| $2.88M | ﹤0.01% |
121,300
+36,420
| +43% | +$1M |
|
2058
Crawford & Co Class A
CRD.A
$542M
| $2.86M | ﹤0.01% |
367,900
-25,972
| -7% | -$209K |
|
|
SFE
2059
DELISTED
Safeguard Scientifics, Inc.
SFE
| $2.85M | ﹤0.01% |
239,717
+7,435
| +3% | +$87.5K |
|
|
WLH
2060
DELISTED
WILLIAM LYON HOMES
WLH
| $2.83M | ﹤0.01% |
117,100
+91,900
| +365% | +$2.05M |
|
2061
Napco Security Technologies
NSSC
$1.3B
| $2.83M | ﹤0.01% |
601,236
+112,092
| +23% | +$548K |
|
|
NGHC
2062
DELISTED
National General Holdings Corp
NGHC
| $2.83M | ﹤0.01% |
+133,900
| New | +$2.95M |
|
|
VRN
2063
DELISTED
Veren
VRN
| $2.82M | ﹤0.01% |
+368,800
| New | +$3.45M |
|
2064
Daktronics
DAKT
$946M
| $2.82M | ﹤0.01% |
292,700
+91,400
| +45% | +$862K |
|
2065
Hingham Institution for Saving
HIFS
$624M
| $2.8M | ﹤0.01% |
15,400
+1,600
| +12% | +$283K |
|
|
HALL
2066
DELISTED
Hallmark Financial Services, Inc.
HALL
| $2.8M | ﹤0.01% |
24,866
+5,837
| +31% | +$626K |
|
2067
Vertex Pharmaceuticals
VRTX
$123B
| $2.8M | ﹤0.01% |
21,700
-18,417
| -46% | -$2.22M |
|
|
KAMN
2068
DELISTED
Kaman Corp
KAMN
| $2.79M | ﹤0.01% |
56,022
-153,900
| -73% | -$7.49M |
|
|
EVOL
2069
DELISTED
Evolving Systems, Inc.
EVOL
| $2.79M | ﹤0.01% |
541,499
+33,050
| +7% | +$168K |
|
2070
INNOVATE Corp
VATE
$106M
| $2.78M | ﹤0.01% |
47,283
+27,673
| +141% | +$1.59M |
|
2071
TransAlta
TAC
$3.93B
| $2.78M | ﹤0.01% |
434,000
+27,400
| +7% | +$152K |
|
2072
Allient
ALNT
$1.34B
| $2.77M | ﹤0.01% |
152,550
+25,950
| +20% | +$428K |
|
|
PCO
2073
DELISTED
Pendrell Corporation - Class A
PCO
| $2.76M | ﹤0.01% |
3,821
+1,534
| +67% | +$959K |
|
|
SEAC
2074
DELISTED
Seachange International Inc
SEAC
| $2.76M | ﹤0.01% |
51,881
+3,436
| +7% | +$174K |
|
|
XIFR
2075
XPLR Infrastructure LP
XIFR
$1.04B
| $2.76M | ﹤0.01% |
+74,500
| New | +$2.57M |
|
Similar funds
Renaissance Technologies's Q2 2017 Portfolio in Review
As of Q2 2017, Renaissance Technologies held 3,586 positions worth $78.4B, up 9.5% from $71.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
Renaissance Technologies deployed $4.59B of net new capital in Q2 2017, opening 398 new positions and adding to 1,648 existing holdings. Its largest new stake was Pfizer: 8,421,609 shares worth $268M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Comcast, an estimated $263M trimmed.
- Renaissance Technologies's largest Q2 2017 buy was Pfizer: 8,421,609 shares worth $268M.
- Renaissance Technologies added most to Bristol-Myers Squibb in Q2 2017, an estimated $382M increase.
- Renaissance Technologies's biggest Q2 2017 reduction was Comcast, cutting an estimated $263M.
- Renaissance Technologies fully exited Booking.com in Q2 2017, selling an estimated $358M.
- Renaissance Technologies's ten largest holdings make up 9% of its $78.4B portfolio in Q2 2017.
- Renaissance Technologies opened 398 new positions and closed 418 in Q2 2017.
- Renaissance Technologies's portfolio value rose 9.5% quarter-over-quarter to $78.4B.
Based on Renaissance Technologies's 13F filing for Q2 2017, filed 11 Aug 2017.